Top
  1. Home
  2. About
  3. Editorial Board

Editorial Board

Editor-in-Chief

Editorial Board Members

  • Aamir Ahmad
    Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Suresh V. Ambudkar
    Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD, USA.
  • Yehuda G. Assaraf
    Fred Wyszkowski Cancer Research Laboratory, Technion - Israel Institute of Technology, Haifa, Israel.
  • Joseph R. Bertino
    Departments of Pharmacology and Medicine, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
  • Benjamin Bonavida
    Department of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
  • Stergios Boussios
    Oncology Department，Medway NHS Foundation Trust, Kent, UK.
  • Ingolf Cascorbi
    Institute of Experimental and Clinical Pharmacology, Christian Albrechts University Kiel, Hospitalstr. 4, Kiel, Germany.
  • Claudio Cerchione
    Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) Srl-IRCCS, Meldola, Italy.
  • Paul Dent
    Department of Biochemistry and Molecular Biology, Virginia Commonwealth University, Richmond, VA, USA.
  • Thomas Efferth
    Department of Pharmaceutical Biology, Institute of Biochemistry and Pharmacy, Johannes Gutenberg University, Staudinger Weg 5, Mainz, Germany.
  • Wafik S. El-Deiry
    Department of Pathology and Laboratory Medicine, Brown University, Providence, RI, USA.
  • Giovannetti Elisa
    Lab Medical Oncology, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands; Cancer Pharmacology Lab, AIRC Start-Up Unit, University of Pisa, Pisa, Italy.
  • Carlos G. Ferreira
    Oncoclinica Group, Oncoclinical Institute, Rio de Janeiro, Brazil.
  • Jean-Pierre Gillet
    Department of Biomedical Sciences, Faculty of Medicine, University of Namur, Namur, Belgium.
  • William Henry Gmeiner
    Department of Cancer Biology, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
  • Ivana Grivicich
    Cancer Biology Laboratory, Lutheran University of Brazil, Canoas, Brazil.
  • Sanjay Gupta
    Department of Urologic Oncology, Case Western Reserve University, Cleveland, Ohio, USA.
  • Georg Hempel
    Clinical Pharmacy Group, Department of Pharmaceutical and Medical Chemistry, University of Münster, Münster, Germany.
  • Dominique Heymann
    Institut de Cancérologie de l'Ouest, Université de Nantes, Saint-Herblain, France.
  • Marja Jäättelä
    Cell Death and Metabolism Unit, Center for Autophagy, Recycling and Disease, Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Gerrit Jansen
    Department of Rheumatology, Amsterdam Rheumatology and immunology Center (ARC), Cancer Center Amsterdam, VU University Medical Center, Amsterdam, The Netherlands.
  • Markus Joerger
    Division of Medical Oncology, University of Basel, Basel, Switzerland.
  • Michael Kahn
    Department of Molecular Medicine, City of Hope's comprehensive cancer center, Duarte, CA, USA.
  • Ganna Kalayda
    Institute of Pharmacy, University of Bonn, Bonn, Germany.
  • Hang Fai Kwok
    Faculty of Health Sciences, University of Macau, Macau, China.
  • Lucia R. Languino
    Department of Cancer Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.
  • Thomas Litman
    Faculty of Health and Medical Sciences, Department of Immunology & Microbiology, University of Copenhagen, Copenhagen, Denmark.
  • Jose J. G. Marin
    Laboratory of Experimental Hepatology and Drug Targeting, National Institute for Study of Liver and Gastrointestinal Diseases, University of Salamanca, Salamanca, Spain.
  • Giovanni Martinelli
    Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) Srl-IRCCS, Meldola, Italy.
  • Larry H. Matherly
    Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, USA.
  • Cornelis J. M. Melief
    Department of Immunohematology and Bloodtransfusion, Leiden University Medical Center, Leiden, The Netherlands.
  • Martin Michaelis
    School of Biosciences, University of Kent, Canterbury, UK.
  • Hans Minderman
    Division of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA.
  • Enrico Mini
    Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Florence, Florence, Italy.
  • Priyabrata Mukherjee
    Department of Pathology, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
  • Patrycja Nowak-Sliwinska
    Molecular Pharmacology, School of Pharmaceutical Sciences (EPGL), University of Geneva, Geneva, Switzerland.
  • Paola Perego
    Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy.
  • Roger M. Phillips
    School of Pharmacy, University of Huddersfield, Huddersfield, UK.
  • Raphael E. Pollock
    Department of Surgery, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.
  • Chiara Riganti
    Department of Oncology, University of Torino Torino, Italy.
  • Jose Antonio Rodriguez
    Department of Genetics, Physical Anthropology and Animal Physiology (School of Medicine) of the University of the Basque Country (UPV/EHU), Basque Country, Spain.
  • José Rueff
    Nova Medical School (NMS), Universidade Nova de Lisboa/Faculty of Medical Sciences, New University of Lisbon, Lisbon, Portugal.
  • Afshin Samali
    Apoptosis Research Centre, National University of Ireland, Galway, Ireland.
  • Gautam Sethi
    Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • John F. Seymour
    Department of Clinical Haematology, The Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Parkville, Australia.
  • Xiang-Yang Shi
    State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Chemistry, Chemical Engineering and Biotechnology, Donghua University, Shanghai, China.
  • Alexander Sparreboom
    Division of Pharmaceutics & Pharmaceutical Chemistry College of Pharmacy, The Ohio State University, Columbus, OH, USA.
  • Rakesh K. Srivastava
    Stanley S. Scott Cancer Center, and Department of Genetics, Louisiana State University Health Sciences Center, New Orleans, LA, United States.
  • Gary S. Stein
    Department of Biochemistry, University of Vermont Larner College of Medicine, Burlington, VT, USA.
  • Ulrike Stein
    Translational Oncology of Solid Tumors, Experimental and Clinical Research Center, Charité – Universitätsmedizin und Max-Delbrück-Centrum für Molekulare Medizin, Berlin, Germany.
  • Haruhiko Sugimura
    Department of Tumor Pathology, Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Shi-Yong Sun
    Department of Hematology and Medical Oncology, Emory University School of Medicine and Winship Cancer Institute, Atlanta, GA, USA.
  • Vladimir P. Torchilin
    Department of Pharmaceutical Sciences, School of Pharmacy, Bouvé College of Health Sciences, Northeastern University, Boston, MA, USA.
  • Takanori Ueda
    Department of Hematology and Oncology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
  • Brian A. Van Tine
    Department of Medicine, Division of Medical Oncology, Washington University in St. Louis, St. Louis, MO, USA.
  • Robert C.A.M. van Waardenburg
    Department of Pharmacology and Toxicology, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Takahiro Yamauchi
    Department of Hematology and Oncology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
  • Nadia Zaffaroni
    Molecular Pharmacology Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.